Compositions and methods for treating retinal degradation
US12274701B2 · kind B2 · utility
0Cited by
13References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 13, 2023 |
| Grant date | Apr 15, 2025 |
| Priority date | — |
| Expiry date | Mar 13, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to compositions and methods for treating retinal damage and/or retinal degradation. More specifically, this disclosure relates to methods for treating degradation of the retinal pigment epithelium by administering compositions comprising a nucleoside and/or a nucleoside or nucleotide reverse transcriptase inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.